Skip to main content
SpringerLink
Log in

Type 1 Diabetes in Autoimmune Syndromes

  • Chapter
Type 1 Diabetes

Part of the book series: Contemporary Endocrinology ((COE))

  • 565 Accesses

Abstract

Two fundamentally different autoimmune polyendocrine syndromes (APSs) are generally recognized, and type 1 diabetes mellitus is common in both (see Table 1). APS type 1 (APS-1) or autoimmune polyendocrinopathy—candidiasis—ectodermal dystrophy (APECED) is an autosomal recessive disease. It can often be diagnosed by clinical criteria (presence of mucocutaneous candidiasis and/or hypoparathyroidism, which do not occur in APS-2) or by DNA analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Betterle C, Volpato MJ, Greggio NA, Presotto F. Type 2 polyglandular autoimmune disease. J Pediatr Endocrinol Metab 1996;9:113–123.

    PubMed  Google Scholar 

  2. Neufeld M, Maclaren N, Blizzard RM. Two types of autoimmune Addison’s disease associated with different polyglandular autoimmune syndromes. Medicine 1981;60:355–362.

    PubMed  CAS  Google Scholar 

  3. Trence DL, Morley JE, Handwerger BS. Polyglandular autoimmune syndrome. Am J Med 1984;77:107–116.

    PubMed  CAS  Google Scholar 

  4. Redondo MJ, Eisenbarth GS. Autoimmune polyendocrine syndrome type II. In: Eisenbarth GS, ed. Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity. Landes, Austin, TX, 1999, pp. 44–61.

    Google Scholar 

  5. Maenpaa J, Raatikka M, Rasanen J, Taskinen J, Wager O. Natural course of juvenile autoimmune thyroiditis.J Pediatr 1985;107:898–904.

    CAS  Google Scholar 

  6. De Bellis A, Bizarro A, Rossi R, et al. Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies. J Clin Endocrinol Metab 1993;76:1002–1007.

    PubMed  Google Scholar 

  7. Tuomi T, Bjorses P, Falorni A, et al. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 1996;81:1488–1494.

    PubMed  CAS  Google Scholar 

  8. Lethagen AL, Ericsson UB, Hallengren B, Groop L, Tuomi T. GADab positivity is associated with an impaired insulin response to glucose and arginine in nondiabetic patients with autoimmune thyroiditis. J Clin Endocrinol Metab 2002;87(3):1177–1183.

    PubMed  CAS  Google Scholar 

  9. Bednarek J, Furmaniak J, Wedlock N. Steroid 21-hydroxylase is a major autoantigen in idopathic Addison’s disease. FEBS Lett 1992;309:51–55.

    PubMed  CAS  Google Scholar 

  10. Winqvist 0, Karlsson FA, Kampe O. 21-hydroxylase, a major autoantigen in idiopathic Addison’s disease. Lancet 1992;339:1559–1562.

    PubMed  Google Scholar 

  11. Uibo R, Aavik E, Peterson P, et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and isolated Addison’s disease. J Clin Endocrinol Metab 1994;78:223–328.

    Google Scholar 

  12. Uibo R, Perheentupa J, Ovod V, Krohn KJE. Characterization of adrenal autoantigens recognized by sera from patients with autoimmune polyglandular syndrome (APS) type I. J Autoimmun 1994;7:399–411.

    PubMed  CAS  Google Scholar 

  13. Winqvist 0, Gustafsson J, Rorsman F, Karlsson FA, Kempe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison’s disease. J Clin Invest 1993;92:2377–2385.

    Google Scholar 

  14. Winqvist O, Gebre-Medhin G, Gustafsson J, et al. Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure. J Clin Endocrinol Metab 1995;80:1717–1723.

    PubMed  CAS  Google Scholar 

  15. Arif S, Vallian S, Farzaneh F, et al. Identification of 3 β-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab 1996;81:4439 1145.

    Google Scholar 

  16. Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K. Identification by molecular cloning of an autoantigen associated with Addison’s disease as steroid 17 alpha-hydroxylase. Lancet 1992;339:770–773.

    PubMed  CAS  Google Scholar 

  17. Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 1987;64:494–500.

    PubMed  CAS  Google Scholar 

  18. Li Y, Song Y, Rais N, et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996;97:910–914.

    PubMed  CAS  Google Scholar 

  19. Burman P, Mardh S, Norberg, Karlsson FA. Parietal cell antibodies in pernicious anemia inhibit H+, K+-adenosine triphosphatase, the proton pump of the stomach. Gastroenterology 1989;96:1434–1438.

    PubMed  CAS  Google Scholar 

  20. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997;337:1441–1448.

    PubMed  CAS  Google Scholar 

  21. Manns MP, Griffin KJ, Quattrochi L, et al. Identification of cytochrome P450IA2 as a human autoantigen. Arch Biochem Biophys 1990;280:229–232.

    PubMed  CAS  Google Scholar 

  22. Clemente MG, Obermayer-Straub P, Meloni A, et al. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1997;82:1353–1361.

    PubMed  CAS  Google Scholar 

  23. Obermayer-Straub P, Perheentupa J, Braun S, et al. Hepatic auto-antigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Gastroenterology 2001;121:668–677.

    PubMed  CAS  Google Scholar 

  24. Hedstrand H, Perheentupa J, Ekwall O, et al. Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I. J Invest Dermatol 1999;113:1054–1058.

    PubMed  CAS  Google Scholar 

  25. Hedstrand H, Ekwall O, Haavik J, et al. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type 1. Biochem Biophys Res Commun 2000;267:456–461.

    PubMed  CAS  Google Scholar 

  26. Song Y- H, Conner E, Li Y, Zorovich B, Balducci P, Maclaren NL. The role of tyrosinase in autoimmune vitiligo. Lancet 1994;344:1049–1052.

    PubMed  CAS  Google Scholar 

  27. Hedstrand H, Ekwall O, Olsson MJ, et al. The transcription factors SOX 9 and SOX 10 are melanocyte autoantigens related to vitiligo in autoimmune polyendocrine syndrome type I. J Biol Chem 2001;276:35,390–35,395.

    Google Scholar 

  28. Ekwall O, Hedstrand H, Grimelius L, et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 1998;352:279–283.

    PubMed  CAS  Google Scholar 

  29. Canale VC, Smith CH. Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr 1967;70:891–899.

    PubMed  CAS  Google Scholar 

  30. Zlotogora J, Shapiro MS. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 1992;29:824–826.

    PubMed  CAS  Google Scholar 

  31. Rosatelli MC, Meloni A, Meloni A, et al. A common mutation in Sardinian autoimmune polyendocrinopathy-candidasis-ectodermal dystrophy patients. Hum Genet 1998;103:428–434.

    PubMed  CAS  Google Scholar 

  32. Halonen M, Pelto-Huikko M, Eskelin P, Peltonen L, Ulmanen I, Kolmer M. Subcellular location and expression pattern of autoimmune regulator (Aire), the mouse orthologue of human gene defective in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J Histochem Cytochem 2001;49:197–208.

    PubMed  CAS  Google Scholar 

  33. Mittaz L, Rossier C, Heino M, et al. Isolation and characterization of the mouse Aire gene. Biochem Biophys Res Commun 1999;255:483–490.

    PubMed  CAS  Google Scholar 

  34. Bjorses P, Halonen M, Palvimo JJ, et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet 2000;66:378–392.

    PubMed  CAS  Google Scholar 

  35. Halonen M, Eskelin P, Myhre, A-G, et al. AIRE mutations and human leukocyte antigen genotypes as determinants of the Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy phenotype. J Clin End Metab 2002;87:2568–2574.

    CAS  Google Scholar 

  36. Blechschmidt K, Schweiger M, Wertz K, et al. The mouse Aire gene: comparative genomic sequencing, gene organization, and expression. Genome Res 1999;9:158–166.

    PubMed  CAS  Google Scholar 

  37. Bjorses P, Pelto-Huikko M, Kaukonen J, Aaltonen J, Peltonen L, Ulmanen I. Localization of the APECED protein in distinct nuclear structures. Hum Mol Genet 1999;8:259–266.

    PubMed  CAS  Google Scholar 

  38. Rinderle C, Christensen HM, Schweiger S, Lehrach H, Yaspo ML. AIRE encodes a nuclear protein co-localizing with cytoskeletal filaments: altered sub-cellular distribution of mutants lacking the PHD zinc fingers. Hum Mol Genet 1999;8:277–290.

    PubMed  CAS  Google Scholar 

  39. Pitkanen J, Doucas V, Sternsdorf T, et al. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem 2000;275:16,802–16,809.

    Google Scholar 

  40. Zuklys S, Balciunaite G, Agarwal A, Fasler-Kan E, Palmer E, Hollander GA. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol 2000;165:1976–1983.

    PubMed  CAS  Google Scholar 

  41. Heino M, Peterson P, Kudoh J, et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun 1999;257:821–825.

    PubMed  CAS  Google Scholar 

  42. Heino M, Scott HS, Chen Q, et al. Mutation analyses of North American APS-1 patients. Hum Mutat 1999;13:69–74.

    PubMed  CAS  Google Scholar 

  43. Scott HS, Heino M, Peterson P, et al. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol 1998;12:1112–1119.

    PubMed  CAS  Google Scholar 

  44. Nagamine K, Peterson P, Scott HS, et al. Positional cloning of the APECED gene. Nat Genet 1997;17:393–398.

    PubMed  CAS  Google Scholar 

  45. Pearce SH, Cheetham T, Imrie H, et al. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet 1998;63:1675–1684.

    PubMed  CAS  Google Scholar 

  46. Ward L, Paquette J, Seidman E, et al. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab 1999;84:844–852.

    PubMed  CAS  Google Scholar 

  47. The Finnish-German APECED Consortium. An Autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997;17:399–403.

    Google Scholar 

  48. Ahonen P, Myllarniemi S, Sipil I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322:1829–1836.

    PubMed  CAS  Google Scholar 

  49. Perheentupa J. Autoimmune endocrinopathy-candidiasis-ectodermal dystrophy (APECED). Horm Metab Res 1996;28:353–356.

    PubMed  CAS  Google Scholar 

  50. Betterle C, Greggio NA, Volpato MJ. Autoimmune polyglandular syndrome type I. J Clin Endocrinol Metab 1998;83:1049–1055.

    PubMed  CAS  Google Scholar 

  51. Perheentupa J, Miettinen A. Autoimmune polyendocrine syndrome type I. In: Eisenbarth GS, ed. Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity: Landes, Austin, TX, 1999, pp. 19–40.

    Google Scholar 

  52. Tsatsoulis A, Shalet SM. Antisperm antibodies in the polyglandular autoimmune syndrome type I: response to cyclical steroid therapy. Clin Endocrinol 1991;35:299–303.

    CAS  Google Scholar 

  53. Franzese A, Valerio G, Di Mario S, Iannucci MP, Bloise A, Tenore A. Growth hormone insufficiency in a girl with the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Endocrinol Invest 1999;22:66–69.

    PubMed  CAS  Google Scholar 

  54. Scherbaum WA, Wass JAH, Besser GM, Bottazo GF, Doniach D. Autoimmune cranial diabetes insipidus: its association with other endocrine diseases and with histiocytosis X. Clin Endocrinol 1986;25:411–420.

    CAS  Google Scholar 

  55. Arvanitakis C, Knouss RE Selective hypopituitarism. Impaired cell-mediated immunity and chronic mucocutaneous candidiasis. JAMA 1973;225(12):1492–1495.

    PubMed  CAS  Google Scholar 

  56. Michele TM, Fleckenstein J, Sprignoli AR, Thuluvath PJ. Chronic active hepatitis in the type I polyglandular autoimmune syndrome. Postgrad Med J 1994;70:128–131.

    PubMed  CAS  Google Scholar 

  57. Friedman TC, Thomas PM, Fleischer TA, Feuillan P, Parker RI, Cassorla F. Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyendocrine disease type I. Am J Med 1991;91:625–630.

    PubMed  CAS  Google Scholar 

  58. Merenmies L, Tarkkanen A. Chronic bilateral keratitis in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Acta Ophthalmol Scand 2000;78:532–535.

    PubMed  CAS  Google Scholar 

  59. Parker RI, O’Shea P, Forman EN. Acquired splenic atrophy in a sibship with the autoimmune polyendocrinopathy-candidiasis syndrome. J Pediatr 1990;117:591–593.

    PubMed  CAS  Google Scholar 

  60. Myllarniemi S, Perheentupa J. Oral findings in the autoimmune polyendocrinopathy-candidiasis syndrome and other forms of hypoparathyroidism. Oral Surg 1978;45:721–729.

    PubMed  CAS  Google Scholar 

  61. Lukinmaa P-L, Waltimo J, Pirinen S. Microanatomy of the dental enamel in autoimmune polyendocrinopathy-candidiasisis-ectodermal dystrophy: report of three cases. J Craniofac Genet Dev Biol 1996;16:174–181.

    PubMed  CAS  Google Scholar 

  62. Padeh S, Theodor R, Jonas A, Passwell JH. Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression. Arch Dis Child 1997;76:532–534.

    PubMed  CAS  Google Scholar 

  63. Sciré G, Magliocca FM, Cianfarani S, Scalamandrè A, Petrozza V, Bonamico M. Autoimmune polyendocrine candidiasis syndrome with associated chronic diarrhea caused by intestinal infection and pancreas insufficiency. J Pediatr Gastroenterol Nutr 1991;13:224–227.

    PubMed  Google Scholar 

  64. Bereket A, Lowenheim M, Blethen SL, Kane P, Ichyama AJ. Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type I and steatorrhea. J Clin Endocrinol Metab 1995;80:933–935.

    PubMed  CAS  Google Scholar 

  65. Gylling M, Tuomi T, Bjorses P, et al. Beta-cell antibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2000;85(12):4434–4440.

    PubMed  CAS  Google Scholar 

  66. Carlsson L, Sundkvist G, Groop L, Tuomi T. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab 2000;85:76–80.

    PubMed  CAS  Google Scholar 

  67. Förster G, Krummenauer F, Kuhn I, Beyer J, Kahaly G. Das polyglandul re autoimmunsyndrom Typ II: epidemiologie und manifesationsformen. Dtsch Med Wochenschr 1999;124:1476–1481.

    PubMed  Google Scholar 

  68. Yu L, Brewer W, Gates S, et al. DRB 1 *04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison’s disease. J Clin Endocrinol Metab 1999;84:328–335.

    PubMed  CAS  Google Scholar 

  69. Gough SCL. The genetics of Graves’ disease. Endocrinol Metab Clin North Am 2000;29(2):255–266.

    PubMed  CAS  Google Scholar 

  70. Trier JS. Celiac sprue. N Engl J Med 1991;325:1709–1719.

    PubMed  CAS  Google Scholar 

  71. Barbesino G, Chiovato L. The genetics of Hashimoto’s disease. Endocrinol Metab Clin North Am 2000;29(2):357–374.

    PubMed  CAS  Google Scholar 

  72. Badenhoop K. CTLA4 variants in type 1 diabetes: some stirrups serve better backing endocrine autoimmunity. Clin Endocrinol 2000;52(2):139–140.

    CAS  Google Scholar 

  73. Djilali-Saiah I, Larger E, Harfouch-Hammoud E, et al. No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 1998;47(1):125–127.

    PubMed  CAS  Google Scholar 

  74. Agarwal K, Jones DEJ, Daly AK, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000;32(4):538–541.

    PubMed  CAS  Google Scholar 

  75. Vaidya B, Imrie H, Perros P, et al. Evidence for a new Graves’ disease susceptibility locus at chromosome 18q21. Am J Hum Genet 2000;66(5):1710–1714.

    PubMed  CAS  Google Scholar 

  76. Kontiainen S, Schlenzka A, Koskimies S, Rilva A, Maenpaa J. Autoantibodies and autoimmune diseases in young diabetics. Diabetes Res 1990;13:151–156.

    PubMed  CAS  Google Scholar 

  77. McCanlies E, O’Leary LA, Foley TP, et al. Hashimoto’s thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab 1998;83:1548–1551.

    PubMed  CAS  Google Scholar 

  78. Hansen D, Bennedbaek FN, Hansen LK, Hoier-Madsen M, Jacobsen BB, Hegedus L. Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur J Endocrinol 1999;140:512–518.

    PubMed  CAS  Google Scholar 

  79. Rattarasarn C, Diosdado MA, Ortego J, et al. Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies. Diabetes Res Clin Pract 2000;49:107–111.

    PubMed  CAS  Google Scholar 

  80. Gerstein HC. Incidence of postpartum thyroid dysfunction in patients with type 1 diabetes mellitus. Ann Intern Med 1993;118(6):419–423.

    PubMed  CAS  Google Scholar 

  81. Riley W, Maclaren NK, Lezotte DC, Spillar RP, Rosenbloom AL. Thyroid autoimmunity in insulindependent diabetes mellitus: the case for routine screening. J Pediatr 1981;98(3):350–354.

    Google Scholar 

  82. Maclaren NK, Riley WJ. Thyroid, gastric, and adrenal autoimmunities associated with insulindependent diabetes mellitus. Diabetes Care 1985;8(Suppl 1):34–38.

    PubMed  Google Scholar 

  83. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark A, Sundkvist G. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 1989;32:387–395.

    PubMed  CAS  Google Scholar 

  84. Landin-Olsson M, Karlsson FA, Lernmark A, Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 1992;41:1022–1027.

    PubMed  CAS  Google Scholar 

  85. Vahasalo P, Petays T, Knip M, et al. Relation between antibodies to islet cell antigens, other autoantigens and cow’s milk proteins in diabetic children and unaffected siblings at the clinical manifestation of IDDM. Autoimmunity 1996;23:165–174.

    PubMed  CAS  Google Scholar 

  86. Verge CF, Howard NJ, Rowley MJ, et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994;37:1113–1120.

    PubMed  CAS  Google Scholar 

  87. De Block CE, De Leeuw IH, Van Gaal LF. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J Clin Endocrinol Metab 1999;84:4062–4067.

    PubMed  Google Scholar 

  88. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977;7:481–493.

    CAS  Google Scholar 

  89. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985;145(8):1386–1388.

    PubMed  CAS  Google Scholar 

  90. Ungar B, Stocks AE, Martin FI, Whittingham S, Mackay IR. Intrinsic-factor antibody, parietal-cell antibody, and latent pernicious anemia in diabetes mellitus. Lancet 1968;2(7565):415–418.

    PubMed  CAS  Google Scholar 

  91. Cronin CC, Shananan F. Insulin-dependent diabetes mellitus and coeliac disease. Lancet 1997;349(9058):1096–1097.

    PubMed  CAS  Google Scholar 

  92. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen in celiac disease. Nat Med 1997;3(7):797–801.

    PubMed  CAS  Google Scholar 

  93. Savilahti E, Simell O, Koskimies S, Rilva A, Akerblom HK. Celiac disease in insulin-dependent diabetes mellitus. J Pediatr 1986;108(5):690–693.

    PubMed  CAS  Google Scholar 

  94. Collin P, Salmi J, Hallstrom O, et al. High frequency of coeliac disease in adult patients with type-I diabetes. Scand J Gastroenterol 1989;24(1):81–84.

    PubMed  CAS  Google Scholar 

  95. Barera G, Bianchi C, Calisti L, et al. Screening of diabetic children for coeliac disease with antigliadin antibodies and HLA typing. Arch Dis Child 1991;66(4):491–494.

    PubMed  CAS  Google Scholar 

  96. Seissler J, Schott M, Boms S, et al. Autoantibodies to human tissue transglutaminase identify silent coeliac disease in type I diabetes. Diabetologia 1999;42:1440–1441.

    PubMed  CAS  Google Scholar 

  97. Saukkonen T, Savilahti E, Reijonen H, et al. Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Childhood Diabetes in Finland Study Group. Diabet Med 1996;13(5):464–470.

    PubMed  CAS  Google Scholar 

  98. Sjoberg K, Eriksson KF, Bredberg A, Wassmuth R, Eriksson S. Screening for coeliac disease in adult insulin-dependent diabetes mellitus. J Intern Med 1998;243(5):133–140.

    PubMed  CAS  Google Scholar 

  99. Bao F, Yu L, Babu S, et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 1999;13(1):143–148.

    PubMed  CAS  Google Scholar 

  100. Carlsson AK, Axelsson IE, Borulf SK, et al. Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents. Pediatrics 1999;103(6):1248–1252.

    PubMed  CAS  Google Scholar 

  101. Kordonouri O, Dieterich W, D S, et al. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with type 1 diabetes mellitus. Diabet Med 2000;17:441–444.

    PubMed  CAS  Google Scholar 

  102. Lampasona V, Bonfanti R, Bazzigaluppi E, et al. Antibodies to tissue transglutaminase C in type I diabetes. Diabetologia 1999;42(10):1195–1198.

    PubMed  CAS  Google Scholar 

  103. Agardh D, Nilsson A, Tuomi T, et al. Tissue transglutaminase autoantibodies associated with HLADQB 1 *02 predict silent coeliac disease at diagnosis of childhood type I diabetes mellitus. Pediatr Endocrinol 2001;2:58–65.

    CAS  Google Scholar 

  104. Willis AC, Vince FP. The prevalence of Addison’s disease in Coventry, UK. Postgrad Med J 1997;73(859):286–288.

    PubMed  CAS  Google Scholar 

  105. Laureti S, Vecchi L, Santeusanio F, Falorni A. Is the prevalence of Addison’s disease underestimated? J Clin Endocrinol Metab 1999;84(5):1762.

    PubMed  CAS  Google Scholar 

  106. Nerup J. Addison’s disease-serological studies. Acta Endocrinol 1974;76(1):42–58.

    Google Scholar 

  107. Betterle C, Volpatao M, Rees Smith B, et al. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: II. Markers of high progression to clinical Addison’s disease. J Clin Endocrinol Metab 1997;82:939–942.

    PubMed  CAS  Google Scholar 

  108. Betterle C, Volpatao M, Rees Smith B, et al. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adults with organ-specific autoimmune diseases: I. Markers of low progression to clinical Addison’s disease. J Clin Endocrinol Metab 1997;82:932–938.

    PubMed  CAS  Google Scholar 

  109. Falorni A, Laureti S, Nikoshkov A, et al. 21-Hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison’s disease. Clin Exp Immunol 1997;107:341–346.

    PubMed  CAS  Google Scholar 

  110. Nerup J. Addison’s disease-clinical studies. A report of 108 cases. Acta Endocrinol 1974;76(1): 127–141.

    PubMed  CAS  Google Scholar 

  111. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974;2:1279–1283.

    PubMed  CAS  Google Scholar 

  112. Seissler J S B, Yassin N, et al. Association between antibodies to MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II. Autoimmunity 1995;19(4):231–238.

    Google Scholar 

  113. Morgenthaler NG, Seissler J, Achenbach P, et al. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome. Autoimmunity 1997;25(4):203–211.

    PubMed  CAS  Google Scholar 

  114. Bosi E, Becker F, Bonifacio E, et al. Progression to type 1 diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes 1991;40:977–984.

    PubMed  CAS  Google Scholar 

  115. Wagner R, Genovese S, Bosi E, et al. Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease. Diabetologia 1994;37(4):365–371.

    PubMed  CAS  Google Scholar 

  116. Betterle C, Presotto F, Magrin L, et al. The natural history of pre-type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases. Diabetologia 1994;37:95–103.

    PubMed  CAS  Google Scholar 

  117. Genovese S, Bonifacio E, McNally JM, et al. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992;35:385–388.

    PubMed  CAS  Google Scholar 

  118. Butler MH, Solimena M, Dirk R Jr, Hayday A, DeCamilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in Stiff-Man syndrome. J Exp Med 1993;178:2097–2106.

    PubMed  CAS  Google Scholar 

  119. Kim J, Namchuk M, Bugawan T, et al. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65 distinguish Stiff-Man-syndrome from insulin-dependent diabetes mellitus. J Exp Med 1994;180:595–606.

    PubMed  CAS  Google Scholar 

  120. Powers AC, Bavik K, Tremble J, Daw K, Scherbaum WA, Banga JP. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders. Clin Exp Immunol 1999;118(3):349–356.

    PubMed  CAS  Google Scholar 

  121. Bjork E, Velloso LA, Kampe O, Karlsson FA. GAD autoantibodies in IDDM, Stiff-Man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994;43(1):161–165.

    PubMed  CAS  Google Scholar 

  122. Tuomi T, Rowley MJ, Knowles W, et al. Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. J Immunol Immunopathol 1994;71:53–59.

    CAS  Google Scholar 

  123. Sohnlein P, Muller M, Syren K, et al. Epitope spreading and a varying but not disease-specific GAD65 antibody response in type 1 diabetes. Diabetologia 2000;43:210–217.

    PubMed  CAS  Google Scholar 

  124. Hallengren B, Falorni A, Landin-Olsson M, Lernmark A, Papadopoulos KI, Sundkvist G. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment. J Intern Med 1996;293:63–68.

    Google Scholar 

  125. Kawasaki E, Abiru N, et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J Autoimmun 1995;8:633–643.

    PubMed  CAS  Google Scholar 

  126. Pietropaolo M, Peakman M, et al. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus. J Autoimmun 1998;11(1):1–10.

    PubMed  CAS  Google Scholar 

  127. Yamaguchi Y, Chikuba N, et al. Islet cell antibodies in patients with autoimmune thyroid disease. Diabetes 1991;40(3):319–322.

    PubMed  CAS  Google Scholar 

  128. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994;35(9):1215–1218.

    PubMed  CAS  Google Scholar 

  129. Volta U, De Franceschi L, Molinaro N, Tetta C, Bianchi FB. Organ-specific autoantibodies in coeliac disease: do they represent an epiphenomenon or the expression of associated autoimmune disorders? Ital J Gastroenterol Hepatol 1997;29(1):18–21.

    PubMed  CAS  Google Scholar 

  130. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999;117:297–303.

    PubMed  CAS  Google Scholar 

  131. Davis RE, McCann VJ, Stanton KG. Type 1 diabetes and latent pernicious anemia. Med J Aust 1992;156:160–162.

    PubMed  CAS  Google Scholar 

  132. Zelissen PMJ, Bast EJEG, Croughs RJM. Associated autoimmunity in Addison’s disease. J Autoimmun 1995;8:121–130.

    PubMed  CAS  Google Scholar 

  133. Soderbergh A, Winqvist O, Norheim I, et al. Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison’s disease. Clin Endocr 1996;45:453–460.

    PubMed  CAS  Google Scholar 

  134. Laureti S, Aubourg P, Calcinaro F, et al. Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab 1998;83(9):3163–3168.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Tiinamaija Tuomi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaakko Perheentupa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Mark A. Sperling MD (Professor of Pediatrics and Chair Emeritus) (Professor of Pediatrics and Chair Emeritus)

  2. Division of Endocrinology, Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

    Mark A. Sperling MD (Professor of Pediatrics and Chair Emeritus) (Professor of Pediatrics and Chair Emeritus)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Tuomi, T., Perheentupa, J. (2003). Type 1 Diabetes in Autoimmune Syndromes. In: Sperling, M.A. (eds) Type 1 Diabetes. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-310-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-310-1_5

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-258-2

  • Online ISBN: 978-1-59259-310-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation